Registry
Organizational structure of the subproject Registry:
- European Treatment and Outcome Study
- Registry
- Molecular Monitoring
- Pharmacological Monitoring
- Spread of Excellence
Organizational structure
Organizational structure
Scientific Committees
Scientific committees have been formed that will be responsible for examining specific scientific questions
Committee | Coordinator |
|---|---|
| Prognostic studies | Jörg Hasford (Germany) |
| Population-based registries | Bengt Simonsson (Sweden) |
| Imatinib failures | Joëlle Guilhot (France) |
| Other / additional chromosomal abnormalities | David Marin (UK) |
| Point mutations | Simona Soverini (Italy) |
| Complete molecular response | Francisco Cervantes (Spain) |
| Imatinib discontinuation in complete responders | Andreas Hochhaus (Germany) |
| Pharmacosurveillance, adverse events | Juan Luis Steegman (Spain) |
Created by: Hellenbrecht , generated 2007/12/19 , last changed: 2008/08/21
Imprint |
Disclaimer |
Sitemap |
Recommend this Site |
© 2007-9 EUTOS: European Treatment and Outcome Study
